Indeed, we validated the HMGA1-ETS1-FKBP12 axis in the susceptibility of ESCC tumors to rapamycin in vivo and demonstrated that HMGA1 deficiency rendered the transplanted tumors insensitive to rapamycin. The gene discussed is ETS1; the disease is esophageal squamous cell carcinoma.